Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1038/srep22298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding cavities and druggability of intrinsically disordered proteins
- (2015) Yugang Zhang et al. PROTEIN SCIENCE
- Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
- (2015) Huabo Wang et al. Oncotarget
- Discovery of Methyl 4′-Methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate, an Improved Small-Molecule Inhibitor of c-Myc-Max Dimerization
- (2014) Jay Chauhan et al. ChemMedChem
- Systems Biology Brings New Dimensions for Structure-Based Drug Design
- (2014) Jianfeng Pei et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
- (2014) Dimitris Stellas et al. JNCI-Journal of the National Cancer Institute
- Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
- (2014) Gergely Tóth et al. PLoS One
- Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors
- (2014) Inga Müller et al. PLoS One
- Inhibitor of MYC identified in a Krohnke pyridine library
- (2014) J. R. Hart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advantages of proteins being disordered
- (2014) Zhirong Liu et al. PROTEIN SCIENCE
- Binding Site Detection and Druggability Prediction of Protein Targets for Structure- Based Drug Design
- (2013) Yaxia Yuan et al. CURRENT PHARMACEUTICAL DESIGN
- How to design a drug for the disordered proteins?
- (2013) Calvin Yu-Chian Chen et al. DRUG DISCOVERY TODAY
- Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide
- (2013) Maximillian Zhu et al. JOURNAL OF CHEMICAL PHYSICS
- Modulation of allostery by protein intrinsic disorder
- (2013) Allan Chris M. Ferreon et al. NATURE
- Ligand Clouds around Protein Clouds: A Scenario of Ligand Binding with Intrinsically Disordered Proteins
- (2013) Fan Jin et al. PLoS Computational Biology
- Mechanisms of small-molecule binding to intrinsically disordered proteins: Figure 1
- (2012) Rémi Cuchillo et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Pharmacophore identification of c-Myc inhibitor 10074-G5
- (2012) Jeremy L. Yap et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Intrinsically disordered proteins and novel strategies for drug discovery
- (2012) Vladimir N. Uversky Expert Opinion on Drug Discovery
- Small-Molecule Inhibition of c-MYC:MAX Leucine Zipper Formation Is Revealed by Ion Mobility Mass Spectrometry
- (2012) Sophie R. Harvey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Protein disorder—a breakthrough invention of evolution?
- (2011) Avner Schlessinger et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Intrinsically disordered proteins from A to Z
- (2011) Vladimir N. Uversky INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Novel Strategies for Drug Discovery Based on Intrinsically Disordered Proteins (IDPs)
- (2011) Jihua Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intrinsically disordered proteins are potential drug targets
- (2010) Steven J Metallo CURRENT OPINION IN CHEMICAL BIOLOGY
- Drugs for ‘protein clouds’: targeting intrinsically disordered transcription factors
- (2010) A Keith Dunker et al. CURRENT OPINION IN PHARMACOLOGY
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization
- (2010) D. M. Clausen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest
- (2010) Kyung-Chae Jeong et al. Molecular BioSystems
- Discovery of Novel Myc−Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model
- (2009) Gabriela Mustata et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinetic Advantage of Intrinsically Disordered Proteins in Coupled Folding–Binding Process: A Critical Assessment of the “Fly-Casting” Mechanism
- (2009) Yongqi Huang et al. JOURNAL OF MOLECULAR BIOLOGY
- Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
- (2009) Dalia I. Hammoudeh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The unfoldomics decade: an update on intrinsically disordered proteins
- (2008) A Keith Dunker et al. BMC GENOMICS
- Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
- (2008) Jianxia Guo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
- (2008) Ariele Viacava Follis et al. CHEMISTRY & BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation